Results 1 to 10 of about 16,218 (165)
Polycythemia Vera Revealed by Acute Myocardial Infarction: A Case Report [PDF]
ReportsBackground and Clinical Significance: Polycythemia vera is a myeloproliferative neoplasm associated with a high thrombotic risk. Although this association is well recognized, acute coronary syndrome as the initial manifestation of polycythemia vera is ...
Jéni Quintal +4 more
doaj +2 more sources
Journal of Bahria University Medical and Dental College, 2021 Polycythemia vera is a medical condition characterized by raised hematocrit. Owing to increased viscosity, the blood flow in the vessels become sluggish leading to the clinical features of polycythemia such as headache, blurring of vision, red skin ...
Nabeela Iqbal +2 more
doaj +1 more source
Prevalence and diagnostic performance of iron deficiency in polycythemia
Hematology, 2023 Introduction Several observations have shown that patients with polycythemia have iron deficiency. Our objectives were to report the prevalence of iron deficiency and to evaluate the diagnostic performance of serum ferritin in polycythemia vera.Patients ...
Rova Malala Fandresena Randrianarisoa +4 more
doaj +1 more source
Polisitemi Veralı Hastalarda Dinamik Thiol/Disulfit Dengesi ve İskemi Modifiye Albumin Düzeyleri
Düzce Tıp Fakültesi Dergisi, 2021 Aim: Polycythemia vera is a chronic myeloproliferative disease characterized by increased red cell mass and JAK2 mutation positivity. Transformation to myelofibrosis and acute leukemia is possible in patients with polycythemia vera.
Özcan Erel +8 more
doaj +1 more source
Polycythemia vera presenting with pulmonary embolism and splenic infarction: a case report
Journal of International Medical Research, 2022 Pulmonary embolism and splenic infarction are rare in patients with polycythemia vera. We herein describe a man in his early 60s whose main symptoms were chest tightness, cough, and sputum expectoration.
Ping Huang, Yuhong Li
doaj +1 more source
Journal of Agromedicine and Medical Sciences (AMS), 2023 Polycythemia vera happened in people around 40-60 years old and mostly men. The criteria are total red blood cells ≥36 mL/kg in males, thrombocytosis, leukocytosis, and JAK2 mutation.
I Gusti Ayu Ratna Dewi +2 more
doaj +1 more source
Muramidase in Polycythemia Vera [PDF]
Blood, 1970 Abstract The serum muramidase levels of 45 patients with polycythemia vera were found to be significantly elevated above the values in 20 normal subjects. The patients with polycythemia vera who were studied included those with active disease, those controlled with myelosuppressive agents and those in the spent phase.
R A, Binder, H S, Gilbert
openaire +2 more sources
Aberrant expression of microRNA in polycythemia vera
Haematologica, 2008 Background Polycythemia vera is a clonal hematopoietic stem cell disorder in which the JAK2 V617F mutation is observed in >95% of patients, but an as yet unidentified process appears to initiate the clonal expansion of hematopoiesis.
Hana Bruchova +2 more
doaj +1 more source
Anesthetic management of a patient with polycythemia vera undergoing emergency repair of a type-A aortic dissection and concomitant coronary artery bypass grafting: a case report [PDF]
Korean Journal of Anesthesiology, 2015 Polycythemia vera is a chronic progressive myeloproliferative disease characterized by increased circulating red blood cells, and the hyperviscosity of the blood can lead to an increased risk of arterial thrombosis.
Hyeongwoo Im +4 more
doaj +1 more source
Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera
Haematologica, 2011 TET2 mutations are found in polycythemia vera and it was initially reported that there is a greater TET2 mutational burden than JAK2V617F in polycythemia vera stem cells and that TET2 mutations precede JAK2V617F.
Sabina I. Swierczek +7 more
doaj +1 more source